Skip to Content

M 515 (Mirtazapine 15 mg)

Pill with imprint M 515 is Beige, Round and has been identified as Mirtazapine 15 mg. It is supplied by Mylan Pharmaceuticals Inc..

Mirtazapine is used in the treatment of depression; major depressive disorder and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M 515

Mirtazapine 15 mg M 515
Mirtazapine 15 mg M 515 Front
Mirtazapine 15 mg M 515 Back
Mirtazapine 15 mg M 515

Mirtazapine

Imprint
M 515
Strength
15 mg
Color
Beige
Size
7.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Tetracyclic antidepressants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
lactose anhydrous, silicon dioxide, croscarmellose sodium, FD&C Blue No. 2, FD&C Yellow No. 6, hypromelloses, magnesium stearate, microcrystalline cellulose, polydextrose, polyethylene glycol, corn starch, sodium lauryl sulfate, titanium dioxide, triacetin

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00378-3515 Mylan Pharmaceuticals Inc.
51079-0086 UDL Laboratories Inc.
54569-5895 A-S Medication Solutions, LLC (repackager)

Get help with Imprint Code FAQs.

Related Images for "M 515"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.